Trial intelligence / Profile preview

Safety and PK of Intrathecal EXPAREL in Healthy Volunteers

NCT04173611Phase 1Terminated

Sponsor
Pacira BioSciences
Start
Jun 2020
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of liposomal bupivacaine in pain (3 arms), sponsored by Pacira BioSciences. Primary endpoints: Area under the plasma concentration-versus-time curve, Maximum plasma concentration and 4 more. Started Jun 2020; status: terminated.

02

Drugs

liposomal bupivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT04173611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04173611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call